期刊文献+

黄药子治疗Graves病有效性和安全性的研究进展

Study on efficacy and safety of Dioscorea bublifera L.in treatment of Graves disease
原文传递
导出
摘要 甲状腺功能亢进症以弥漫性毒性甲状腺肿(Graves disease,GD)最多见,传统的抗甲状腺药物往往难以取得满意的功效,复发率高、疗程长是最为突出的缺点。中药黄药子具有“消瘿”的功效,近年被广泛用于治疗GD,但长期使用可能会导致肝功能和肾功能损害。故黄药子治疗GD的有效性和安全性需更多研究。 Hyperthyroidism is most common in Graves disease(GD),and traditional antithyroid medicine are often difficult to achieve satisfactory efficacy,and high recurrence rate and long course of treatment are the most prominent problems.Huangyaozi(Dioscorea bublifera L.),a traditional Chinese medicine,has the effect of“Xiao Ying”and has been widely used in the treatment of GD in recent years,but long⁃term use may cause liver and kidney damage.Therefore,more research on the efficacy and safety of Huangyaozi need to be done in the treatment of GD.
作者 崔依帆 张瑞祥 韦晓 刘超 CUI Yifan;ZHANG Ruixiang;WEI Xiao;LIU Chao(Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Jiangsu Branch of China Academy of Chinese Medical Science,Nanjing 210028,China)
出处 《内科理论与实践》 2024年第4期273-277,共5页 Journal of Internal Medicine Concepts & Practice
关键词 黄药子 GRAVES病 有效性 安全性 薯蓣皂苷元 肝毒性 Dioscorea bublifera L. Graves disease Efficacy Safety Diosgenin Hepatotoxicity
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部